BPC-157 / TB-500
A combined BPC-157 and TB-500 research blend studied in tissue and recovery models.
What it is
This blend combines BPC-157, a stable pentadecapeptide, with TB-500, a synthetic thymosin beta-4 fragment. Both appear frequently in preclinical tissue and recovery research, and are studied together as a combined reference material in a single vial.
How it is studied
Research on these peptides is preclinical, in cell cultures and animal models exploring tissue and cellular repair processes. The blend is a research compound only, not an approved therapeutic, and model results do not translate to conclusions about people.
Purity and COA
Each component of the blend is third-party lab-tested: identity by mass spectrometry and purity by HPLC, with the Certificate of Analysis provided for the batch you order. Blends are only as reliable as the characterization of every peptide in them, which is why per-batch documentation matters.
Further reading
Search the primary literature and registered studies for BPC-157 / TB-500 on independent research databases. LNK is not affiliated with these sources and does not endorse their conclusions.